Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 5,145 | 3,432 | 2,025 | 1,658 | 1,136 |
| Cost of Goods | 3,982 | 3,139 | 3,160 | 2,247 | 1,992 |
| Gross Profit | 1,163 | 293 | -1,140 | -589 | -856 |
| Operating Expenses | 7,884 | 5,721 | 5,900 | 6,382 | 6,410 |
| Operating Income | -5,739 | -5,289 | -6,875 | -6,724 | -6,274 |
| Interest Expense | 366 | 367 | 390 | 457 | 37 |
| Other Income | 167 | 235 | 445 | 412 | 161 |
| Pre-tax Income | -5,938 | -5,421 | -6,820 | -6,769 | -6,150 |
| Net Income Continuous | -5,938 | -5,421 | -6,854 | -6,769 | -6,150 |
| Net Income | $-5,938 | $-5,421 | $-6,854 | $-6,769 | $-6,150 |
| EPS Basic Total Ops | -0.13 | -0.12 | -0.15 | -0.15 | -0.15 |
| EPS Basic Continuous Ops | -0.13 | -0.12 | -0.15 | -0.15 | -0.15 |
| EPS Diluted Total Ops | -0.13 | -0.12 | -0.15 | -0.15 | -0.15 |
| EPS Diluted Continuous Ops | -0.13 | -0.12 | -0.15 | -0.15 | -0.15 |
| EBITDA(a) | $-5,219 | $-4,777 | $-5,656 | $-5,180 | $-4,551 |